DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01221 C4a(FIV ectodomain 773-776) WVRW FIV 12610147
DRAVPe01222 C4b(FIV ectodomain 774-777) VRWI FIV 12610147
DRAVPe01223 C8W->A770 AEDWVRWI FIV 12610147
DRAVPe01224 C8E->A771 WADWVRWI FIV 12610147
DRAVPe01225 C8D->A772 WEAWVRWI FIV 12610147
DRAVPe01226 C8W->A773 WEDAVRWI FIV 12610147
DRAVPe01227 C8V->A774 WEDWARWI FIV 12610147
DRAVPe01228 C8G->A775 WEDWVAWI FIV 12610147
DRAVPe01229 C8W->A776 WEDWVRAI FIV 12610147
DRAVPe01230 C8I->A777 WEDWVRWA FIV 12610147
DRAVPe01303 Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals) ATCYCRTGRCATRESLSGVCEISGRLYRLCCR SARS-CoV-2,HSV,HIV 34206990,26206286,23269800
DRAVPe01304 HD5[E21R] ATCYCRTGRCATRESLSGVCRISGRLYRLCCR HSV,HIV 23269800
DRAVPe01377 D4E1 FKLRAKIKVRLRAKIKL FIV 12208971
DRAVPe01378 DC1 FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK FIV 12208971
DRAVPe01379 D1D6 FLAAARIAKRVAKKARKLAKRAARKRK FIV 12208971
DRAVPe01380 D4C3 FRFKIKFRLKFRFKARFKFRAKFRA FIV 12208971
DRAVPe01381 D5F FAVGLRAIKRALKKLRRGVRKVAKDL FIV 12208971
DRAVPe01382 D5C1 KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF FIV 12208971
DRAVPe01383 D2B15 GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK FIV 12208971
DRAVPe01384 D2A21 FAKKFAKKFKKFAKKFAKFAFAF FIV 12208971
DRAVPe01385 D2A3 KKKKFVKKVAKKVKKVAKKVAKVAVAV FIV 12208971
DRAVPe01386 D1A22 FLFAFRIFKRVFKKFRKLFKRAF FIV 12208971
DRAVPe01387 D5C KRKRAVKRVGRRLKKKLARKIARLGVAF FIV 12208971
DRAVPe01388 D3A15 KRKRFAKKFLRFLRKVIRFLKRFIRRF FIV 12208971
DRAVPe01389 DP1 FALALKALKKALKKLKKALKKAL FIV 12208971
DRAVPe01390 D1D2 FAIAIKAIKKAIKKIKKAIKKAI FIV 12208971
DRAVPe01391 D4B FKVKAKVKAKVKAKVKAKKKK FIV 12208971
DRAVPe01392 D5D AVKRVGRRLKKLARKIARLGVAF FIV 12208971
DRAVPe01425 Pcr-400 CCFLNITNSHVSILQERPPLENRVLTGWGL HTLV 19114713
DRAVPe01426 Pcr-Δ8 LNITNSHVSILQERPPLENRVL HTLV 19114713
First 21 22 23 24 25 26 27 Last